
Venture capital · Early stage
Qbic
Qbic is a Belgian inter-university venture capital fund that backs spin-offs and start-ups commercialising research from partner universities, research institutes and hospitals.
Investment activity
Round-by-round activity is part of PRO
Key signal this week
Is Qbic right for your round?
Key stats
Fund cycle Public record
Fund vehicles on public registers (ESMA register).
Latest investments
BetaRounds Qbic joined, from press and the firm’s own posts.
1 round in the last 12 months
Round sizes, Qbic’s role and who invested alongside.
Notable portfolio
Portfolio and exits
Every company Qbic backed and how the exits played out.
Where the money goes
Share of companies at first investment, from the rounds we track.
Investment team
Where to meet Qbic
Events where Qbic’s team spoke or showed up, from event programmes, press and the firm’s own posts.
Signals
Register and fund filings are free. Website, team and portfolio changes we pick up are PRO.
Founders also look at
Frequently asked questions
Qbic is based in Belgium.
1 fund vehicle is on public registers (ESMA register), including QBIC II Fund Arkiv S.C.A.
Stages: Seed, Early stage. Sectors: Generalist. From the firm’s own website.
Backs companies that turn academic research into businesses, either spin-offs from its knowledge partners or start-ups with a strong R&D collaboration with them. It usually joins the first external round and keeps supporting and funding the company as it grows. From the firm’s own website.
Qbic lists 23 portfolio companies on its website, including Sightera Biosciences, SpectaCell, AILOS Robotics, Innocens and Pleevi.
Firms whose websites list some of the same companies include BioGeneration Ventures, Era Ventures and GTMfund.
Know before Qbic’s next round is announced.
PRO tracks Qbic’s filings, hires and portfolio changes the day they land, alongside 3,869 other firms.